A signature of 18 immune‐related gene pairs to predict the prognosis of pancreatic cancer patients

Abstract

Pancreatic cancer is one of the most lethal malignancies. With the promising prospects conveyed by immunotherapy in cancers, we aimed to construct an immune‐related gene pairs (IRGPs) signature to predict the prognosis of pancreatic cancer patients. We downloaded clinical and transcriptional data of pancreatic cancer patients from The Cancer Genome Atlas data set as the training group and GSE57495 data set as the verification group. We filtered immune‐related transcriptional data by IMMPORT. With the assistance of lasso penalized Cox regression, we constructed our prognostic IRGPs signature and divided all samples into high‐/low‐risk groups by receiver operating characteristic curve for further comparisons. The comparisons between high‐ and low‐risk groups including survival rate, multivariate, and univariate Cox proportional‐hazards analysis, infiltration of immune cells, and Gene Set Enrichment Analysis (GSEA). Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) are facilitated to analyze the proceedings in which our IRGPs signature may involve in. The results revealed that 18 IRGPs were defined as our prognostic signature. The prognostic value of this IRGPs signature was verified from the GSE57495 data set. We further demonstrated the independent prognostic value of this IRGPs signature. The contents of six immune cells between high‐/low‐risk groups were different, which was associated with the progression of diverse cancers. Results from GO, KEGG, and GSEA revealed that this IRGPs signature was involved in extracellular space, immune response, cancer pathways, cation channel, and gated channel activities. Evidently, this IRGPs signature will provide remarkable value for the therapy of pancreatic cancer patients.

N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy

“…In low-group patients, the upregulation of immune cell infiltration associated with immune activation correlated with improved prognosis for immunotherapy. For example, a study showed that naive B cells and CD8 + T cells appeared to be anticancer immune cells (Zhang et al, 2019;Bu et al, 2020); meanwhile, M2 macrophages, immune cells that promote tumor proliferation and metastasis, were increased in this study (Tariq et al, 2017). Interestingly, clinical trials have shown promising prospects for immunotherapy in patients with the TNBC subtype.…”

Construction of a new immune-related lncRNA model and prediction of treatment and survival prognosis of human colon cancer

“…Identifying immune-related 9-lncRNA signaling can not only improve the ability of colon cancer patients to predict prognosis but also facilitate better clinical strategies and elucidate its potential mechanisms [ 13 ]. We found 18 immune-related genes to predict the prognosis of patients with pancreatic cancer characteristics, proving the validity of the IRGP signature, and validating the model and relationship between the immune cells [ 14 ]. Bioinformatics analysis integrates three immune-related long-term noncoding RNA (mRNA, microRNA, lncRNA) signals, which can be used as a predictive model for clear cell renal cell carcinoma [ 15 ].…”

Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy

“…The current immunotherapeutic approaches have shown a limited improvement in the prognosis for patients with PDAC [ 11 ]. However, several studies reported that a positive response to the therapy and improved prognosis in patients with PDAC are associated with immune activation [ 12 , 13 , 14 , 15 , 16 ]. Therefore, immunotherapy remains a promising treatment option for patients with PDAC.…”